Streetbeat News

Regulatory

ALLR

Allarity Therapeutics received a Wells Notice from the SEC regarding its disclosures about meetings with the FDA concerning its NDA for Dovitinib or Dovitinib-DRP. The company has a cash balance of $20 million, expected to last until 2026, and has paused its ATM usage. Additionally, Allarity's Stenoparib shows extended Phase 2 clinical benefits.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:02 pm

JNJ

Johnson & Johnson has submitted a supplemental new drug application to the FDA for the approval of SPRAVATO CIII nasal spray, aimed at treating treatment-resistant depression.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:01 pm

SSKN

STRATA Skin Sciences has received approval for its XTRAC Momentum 1.0 device in Japan, potentially expanding its market reach and revenue opportunities.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:00 pm

CYN

Cyngn shares are trading higher after the company announced that it regained Nasdaq compliance and confirmed that it will not increase its authorized shares.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:42 am

RTX

RTX (NYSE:RTX) has completed the preliminary design review for its hybrid-electric propulsion demonstrator engine under the SWITCH project, supported by the EU's Clean Aviation Joint Undertaking. The system aims to improve engine efficiency and reduce fuel burn and emissions for future short- and medium-range aircraft.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:41 am

CYN

Cyngn has regained compliance with Nasdaq listing requirements and confirmed that there will be no increase in authorized shares.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:13 am

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) announced that its Germany-based facility, Aphria RX GmbH, has received the first cannabis cultivation license under Germany's new Cannabis Act. This license allows Aphria RX to cultivate and manufacture a wide range of medical cannabis, improving patient access to high-quality medical cannabis in Germany.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:07 am

AMD

FXI

NVDA

SPY

TSM

AI chip stocks Nvidia, AMD, and Taiwan Semiconductor saw mixed movements on Monday following various geopolitical and economic developments. Nvidia and AMD opened higher, while Taiwan Semiconductor opened lower. The broader market and China-focused ETFs also experienced declines last week.

Portfolio Pulse from Anusuya Lahiri

July 22, 2024 | 11:07 am

ANEB

Anebulo Pharmaceuticals has received a $1.9 million grant from the National Institute on Drug Abuse (NIDA) for its investigational IV treatment of cannabis toxic effects. The grant will be disbursed in two tranches, with the initial $0.9 million awarded and the remaining $1 million contingent on meeting certain milestones.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:05 am

ALVO

STADA and Alvotech have launched Uzpruvo, the first approved biosimilar to Stelara in Europe, across major European markets. This launch follows the expiry of exclusivity rights linked to the European reference molecule patent, providing expanded access to a critical medicine in gastroenterology, dermatology, and rheumatology.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:36 am